535 related articles for article (PubMed ID: 20351690)
1. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.
Ma L; Reinhardt F; Pan E; Soutschek J; Bhat B; Marcusson EG; Teruya-Feldstein J; Bell GW; Weinberg RA
Nat Biotechnol; 2010 Apr; 28(4):341-7. PubMed ID: 20351690
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system.
Zhang Q; Ran R; Zhang L; Liu Y; Mei L; Zhang Z; Gao H; He Q
J Control Release; 2015 Jan; 197():208-18. PubMed ID: 25445692
[TBL] [Abstract][Full Text] [Related]
3. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.
Kim J; Siverly AN; Chen D; Wang M; Yuan Y; Wang Y; Lee H; Zhang J; Muller WJ; Liang H; Gan B; Yang X; Sun Y; You MJ; Ma L
Cancer Res; 2016 Nov; 76(21):6424-6435. PubMed ID: 27569213
[TBL] [Abstract][Full Text] [Related]
4. Antagonizing metastasis.
De Palma M; Naldini L
Nat Biotechnol; 2010 Apr; 28(4):331-2. PubMed ID: 20379176
[No Abstract] [Full Text] [Related]
5. Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin.
Yoo B; Greninger P; Stein GT; Egan RK; McClanaghan J; Moore A; Benes CH; Medarova Z
PLoS One; 2018; 13(7):e0201046. PubMed ID: 30028875
[TBL] [Abstract][Full Text] [Related]
6. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Ma L; Teruya-Feldstein J; Weinberg RA
Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
[TBL] [Abstract][Full Text] [Related]
7. Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer.
Yoo B; Kavishwar A; Wang P; Ross A; Pantazopoulos P; Dudley M; Moore A; Medarova Z
Sci Rep; 2017 Mar; 7():45060. PubMed ID: 28322342
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
9. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
10. Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials.
Savan NA; Saavedra PV; Halim A; Yuzbasiyan-Gurkan V; Wang P; Yoo B; Kiupel M; Sempere L; Medarova Z; Moore A
Front Oncol; 2022; 12():959630. PubMed ID: 36387245
[TBL] [Abstract][Full Text] [Related]
11. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma.
He C; Chen ZY; Li Y; Yang ZQ; Zeng F; Cui Y; He Y; Chen JB; Chen HQ
BMC Nephrol; 2019 Apr; 20(1):127. PubMed ID: 30975094
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
13. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.
Ahmad A; Sethi S; Chen W; Ali-Fehmi R; Mittal S; Sarkar FH
Am J Transl Res; 2014; 6(4):384-90. PubMed ID: 25075255
[TBL] [Abstract][Full Text] [Related]
15. Development of microRNA-145 for therapeutic application in breast cancer.
Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.
Dettori D; Orso F; Penna E; Baruffaldi D; Brundu S; Maione F; Turco E; Giraudo E; Taverna D
Mol Ther; 2018 Aug; 26(8):2008-2018. PubMed ID: 29929788
[TBL] [Abstract][Full Text] [Related]
17. Soluble Vegfr3 gene therapy suppresses multi-organ metastasis in a mouse mammary cancer model.
Shibata MA; Shibata E; Tanaka Y; Shiraoka C; Kondo Y
Cancer Sci; 2020 Aug; 111(8):2837-2849. PubMed ID: 32539229
[TBL] [Abstract][Full Text] [Related]
18. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.
Devulapally R; Sekar NM; Sekar TV; Foygel K; Massoud TF; Willmann JK; Paulmurugan R
ACS Nano; 2015 Mar; 9(3):2290-302. PubMed ID: 25652012
[TBL] [Abstract][Full Text] [Related]
19. MiR-10b suppresses the growth and metastasis of colorectal cancer cell by targeting FGF13.
Song JJ; Li W
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):576-587. PubMed ID: 30720165
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
